Heidi Nick

Dr. Heidi Nick

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Infection and Immunity
Verified
Journal Article
Open access
PDF file
EMErin M. McDonald
Erin M. McDonald
MPM. Carolina Pilonieta
M. Carolina Pilonieta
HNHeidi Nick
Heidi Nick
CDCorrella S Detweiler
Corrella S Detweiler
During acute infection with bacteria, viruses or parasites, a fraction of macrophages engulf large numbers of red and white blood cells, a process called hemophagocytosis. Hemophagocytes persist into the chronic stage of infection and have an anti-inflammatory phenotype. Salmonella Typhimurium infection of immunocompetent mice results in acute followed by chronic infection, with the accumulation of hemophagocytes. The mechanism(s) that triggers a macrophage to become hemophagocytic is unknown, but it is reported that the pro-inflammatory cytokine interferon-γ is responsible. We show that primary macrophages become hemophagocytic in the absence or presence of interferon-γ upon infection with Gram-negative bacterial pathogens or prolonged exposure to heat-killed Salmonella enterica, the Gram-positive bacterium Bacillus subtilis, or Mycobacterium marinum. Moreover, conserved microbe-associated molecular patterns are sufficient to stimulate macrophages to hemophagocytose. Purified bacterial lipopolysaccharide induced hemophagocytosis in resting and interferon-γ-pre-treated macrophages, whereas lipoteichoic acid and synthetic unmethylated deoxycytidine-deoxyguanonsine dinucleotides, which mimic bacterial DNA, induced hemophagocytosis only in interferon-γ-pre-treated macrophages. Chemical inhibition or genetic deletion of Toll-like receptor 4, a pattern recognition receptor responsive to LPS, prevented both Salmonella- and lipopolysaccharide-stimulated hemophagocytosis. Inhibition of NFκB also prevented hemophagocytosis. These results indicate that recognition of microbial products by Toll-like receptors stimulates hemophagocytosis, a novel outcome of prolonged Toll-like receptor signaling, suggesting hemophagocytosis is a highly conserved innate immune response.

30 August 2022 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
PDF file
DHDaniel M. Hinds
Daniel M. Hinds
HNHeidi Nick
Heidi Nick
TVTessa M. Vallin
Tessa M. Vallin
LBLeslie A. Bloomquist
Leslie A. Bloomquist
SCSarah Christeson
Sarah Christeson
CWCarl W. White
Carl W. White
E-cigarette vaping is a major aspect of nicotine consumption, especially for children and young adults. Although it is branded as a safer alternative to cigarette smoking, murine and rat models of subacute and chronic e-cigarette vaping exposure have shown many proinflammatory changes in the respiratory tract. An acute vaping exposure paradigm has not been demonstrated in the golden Syrian hamster, and the hamster is a readily available small animal model that has the unique benefit of becoming infected with and transmitting respiratory viruses, including SARS-CoV-2, without genetic alteration of the animal or virus. Using a 2-day, whole body vaping exposure protocol in male golden Syrian hamsters, we evaluated serum cotinine, bronchoalveolar lavage cells, lung, and nasal histopathology, and gene expression in the nasopharynx and lung through reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Depending on the presence of nonnormality or outliers, statistical analysis was performed by ANOVA or Kruskal–Wallis tests. For tests that were statistically significant ( P < 0.05), post hoc Tukey–Kramer and Dunn’s tests, respectively, were performed to make pairwise comparisons between groups. In nasal tissue, RT-qPCR analysis revealed nicotine-dependent increases in gene expression associated with type 1 inflammation ( CCL-5 and CXCL-10), fibrosis [transforming growth factor-β ( TGF-β)], nicotine-independent increase oxidative stress response ( SOD-2), and a nicotine-independent decrease in vasculogenesis/angiogenesis (VEGF-A). In the lung, nicotine-dependent increases in the expression of genes involved in the renin-angiotensin pathway [angiotensin-converting enzyme ( ACE), ACE2], coagulation ( tissue factor, Serpine-1), extracellular matrix remodeling ( MMP-2, MMP-9), type 1 inflammation ( IL-1β, TNF-α, and CXCL-10), fibrosis ( TGF-β and Serpine-1), oxidative stress response ( SOD-2), neutrophil extracellular traps release ( ELANE), and vasculogenesis and angiogenesis ( VEGF-A) were identified. To our knowledge, this is the first demonstration that the Syrian hamster is a viable model of e-cigarette vaping. In addition, this is the first report that e-cigarette vaping with nicotine can increase tissue factor gene expression in the lung. Our results show that even an acute exposure to e-cigarette vaping causes significant upregulation of mRNAs in the respiratory tract from pathways involving the renin-angiotensin system, coagulation, extracellular matrix remodeling, type 1 inflammation, fibrosis, oxidative stress response, neutrophil extracellular trap release (NETosis), vasculogenesis, and angiogenesis.

4 August 2023 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Closed access
PDF file
HNHeidi Nick
Heidi Nick
CJCarly A. Johnson
Carly A. Johnson
ASAmber R. Stewart
Amber R. Stewart
SCSarah E. Christeson
Sarah E. Christeson
LBLeslie A. Bloomquist
Leslie A. Bloomquist
CWCarl W. White
Carl W. White
Inhalation of high levels of sulfur mustard (SM), a potent vesicating and alkylating agent used in chemical warfare, results in acutely lethal pulmonary damage. Sodium 2-mercaptoethane sulfonate (mesna) is an organosulfur compound that is currently FDA-approved for decreasing the toxicity of mustard-derived chemotherapeutic alkylating agents like ifosfamide and cyclophosphamide. The nucleophilic thiol of mesna is a suitable reactant for the neutralization of the electrophilic group of toxic mustard intermediates. In a rat model of SM inhalation, treatment with mesna (3 doses: 300 mg/kg intraperitoneally 20 min, 4 h, and 8 h post-exposure) afforded 74% survival at 48 h, compared to 0% survival at less than 17 h in the untreated and vehicle-treated control groups. Protection from cardiopulmonary failure by mesna was demonstrated by improved peripheral oxygen saturation and increased heart rate through 48 h. Additionally, mesna normalized arterial pH and pACO2. Airway fibrin cast formation was decreased by more than 66% in the mesna-treated group at 9 h after exposure compared to the vehicle group. Finally, analysis of mixtures of a mustard agent and mesna by a DTNB assay and HPLC-MS/MS demonstrate a direct reaction between the compounds. This study provides evidence that mesna is an efficacious, inexpensive, FDA-approved candidate antidote for SM exposure. Significance Statement Despite the use of SM as a chemical weapon for over 100 years, an ideal drug candidate for treatment after real-world exposure situations has not yet been identified. Utilizing a uniformly lethal animal model, the results of the present study demonstrate that mesna is a promising candidate for repurposing as an antidote, decreasing airways obstruction and improving pulmonary gas exchange, tissue oxygen delivery and survival following high level SM inhalation exposure, and warrants further consideration.

29 August 2022 in Journal of Chromatography A
Verified
Journal Article
Closed access
ADAbigail B. Donkor
Abigail B. Donkor
OGObed A. Gyamfi
Obed A. Gyamfi
CWCarl W. White
Carl W. White
HNHeidi Nick
Heidi Nick
JRJacqueline S. Rioux
Jacqueline S. Rioux
BLBrian A. Logue
Brian A. Logue

22 December 2021 in Journal of Chromatography B
Verified
Journal Article
Closed access
ADAbigail B. Donkor
Abigail B. Donkor
CWCarl W. White
Carl W. White
HNHeidi Nick
Heidi Nick
BLBrian A. Logue
Brian A. Logue

21 May 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
DHDaniel M. Hinds
Daniel M. Hinds
HNHeidi Nick
Heidi Nick
TVTessa M. Vallin
Tessa M. Vallin
LBLeslie A. Bloomquist
Leslie A. Bloomquist
SCSarah Christeson
Sarah Christeson
CWCarl W. White
Carl W. White
Introduction: E-cigarette vaping has become a major portion of nicotine consumption, especially for children and young adults. Although it is branded as a safer alternative to cigarette smoking, murine and rat models of sub-acute and chronic e-cigarette vaping exposure have shown many pro-inflammatory changes in the respiratory tract. An acute vaping exposure paradigm has not been demonstrated in the golden Syrian hamster, and the hamster is a readily available small animal model that has the unique benefit of becoming infected with and transmitting SARS-CoV-2 without genetic alteration to the animal or virus. Methods: Using a two-day, whole-body vaping exposure protocol in male golden Syrian hamsters, we evaluated serum cotinine, bronchoalveolar lavage cells, lung and nasal histopathology, and gene expression in the nasopharynx and lung through RT-qPCR. Depending on the presence of nonnormality or outliers, statistical analysis was performed by ANOVA or Kruskal-Wallis tests. For tests that were statistically significant (p-value <0.05), post-hoc Tukey-Kramer and Dunn’s tests, respectively, were performed to make pairwise comparisons between groups. Results: In nasal tissue, RT-qPCR analysis revealed nicotine-dependent increases in genes associated with type 1 inflammation (CCL-5 and CXCL-10), fibrosis (TGF-β), and a nicotine-independent decrease in the vasculogenesis/angiogenesis gene VEGF-A. In the lung, nicotine-dependent increases in the expression of genes involved in the renin-angiotensin pathway (ACE, ACE2), coagulation (tissue factor, Serpine-1), extracellular matrix remodeling (MMP-2, MMP-9), type 1 inflammation (IL-1β, TNF-α, and CXCL-10), fibrosis (TGF-β and Serpine-1), oxidative stress response (SOD-2), neutrophil extracellular traps release (ELANE), and vasculogenesis and angiogenesis (VEGF-A) were identified. Conclusion: To our knowledge, this is the first demonstration that the Syrian hamster is a viable model of e-cig induced inhalational injury. In addition, this is the first report that e-cig vaping with nicotine can increase tissue factor gene expression in the lung. Our results show that even an acute exposure to e-cigarette vaping causes significant upregulation in the respiratory tract of pathways involving the renin-angiotensin system, coagulation, extracellular matrix remodeling, type 1 inflammation, fibrosis, oxidative stress response, NETosis, vasculogenesis, and angiogenesis.